Related references
Note: Only part of the references are listed.Specificity of Ertapenem Susceptibility Screening for Detection of Klebsiella pneumoniae Carbapenemases
Shannon E. McGettigan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae
Louis B. Rice et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene
Thierry Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
Mitchell J. Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC plus qnrB4) and a blaIMP-4 gene
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital
Azita Leavitt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobactetiaceae
K. F. Anderson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China
Rong Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
KPC type β-lactamase, rural Pennsylvania
Jonathan Pope et al.
EMERGING INFECTIOUS DISEASES (2006)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York
BM Lomaestro et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mechanisms of resistance to quinolones
GA Jacoby
CLINICAL INFECTIOUS DISEASES (2005)
Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection
S Bratu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
YG Kwak et al.
MICROBIAL DRUG RESISTANCE (2005)
Fluoroquinolone prescribing in the United States: 1995 to 2002
JA Linder et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units:: Role of antibiotics with antipseudomonal activity
E Paramythiotou et al.
CLINICAL INFECTIOUS DISEASES (2004)
Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: Impact of priop fluoroquinolone use?
CV Gould et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
JM Streit et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Outbreak of Klebsiella pneumoniae producing a new carbapenern hydrolyzing class a β-lactamase, KPC-3, in a New York Medical Center
N Woodford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use
MM Neuhauser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review
AD Harris et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
